Cytosorbents (NasdaqCM:CTSO) Q1 2026 Earnings call May 13, 2026 04:30 PM ET Company ParticipantsEfthymios Deliargyris - Chief Medical OfficerPeter Mariani - CFOPhillip Chan - CEOSean Lee - VP of Equity ResearchConference Call ParticipantsMichael Sarcone - Equity Research AnalystThomas Kerr - Senior Equity Research AnalystOperatorAfternoon, ladies and gentlemen, and welcome to the CytoSorbents' first quarter 2026 earnings conference call. At this time, all lines are in listen-only mode. After the speaker's r ...